These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34848889)

  • 1. Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19.
    Morgado-Carrasco D; Ibaceta-Ayala J; Piquero-Casals J
    Actas Dermosifiliogr; 2021 Nov; ():. PubMed ID: 34848889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].
    Morgado-Carrasco D; Ibaceta-Ayala J; Piquero-Casals J
    Actas Dermosifiliogr; 2022 Feb; 113(2):166-175. PubMed ID: 34366433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antimalarials in dermatology.
    Ochsendorf FR
    J Dtsch Dermatol Ges; 2010 Oct; 8(10):829-44; quiz 845. PubMed ID: 20678149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda.
    Sunkara B; Roofeh D; Silver S; Pearson TL; Ettel M; McCune WJ
    Lupus; 2018 Jul; 27(8):1383-1386. PubMed ID: 29631513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of hydroxychloroquine in dermatology: A multicenter retrospective study in Korea.
    Lim JW; Lee JH; Kim HJ
    J Dermatol; 2022 Jan; 49(1):173-178. PubMed ID: 34713476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Skin diseases and hepatitis virus C infection].
    Poljacki M; Gajinov Z; Ivkov M; Matić M; Golusin Z
    Med Pregl; 2000; 53(3-4):141-5. PubMed ID: 10965678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Janus-kinase inhibitors in dermatology: A review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease.
    Huang MY; Armstrong AW
    Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):30-40. PubMed ID: 38031699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimalarial drugs in contemporary dermatologic therapy].
    Kiedrowicz M; Kacalak-Rzepka A; Bielecka-Grzela S; Maleszka R
    Ann Acad Med Stetin; 2011; 57(1):38-44. PubMed ID: 22593989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
    Doyno C; Sobieraj DM; Baker WL
    Clin Toxicol (Phila); 2021 Jan; 59(1):12-23. PubMed ID: 32960100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine in dermatology: New perspectives on an old drug.
    Chew CY; Mar A; Nikpour M; Saracino AM
    Australas J Dermatol; 2020 May; 61(2):e150-e157. PubMed ID: 31612996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.
    Bansal P; Goyal A; Cusick A; Lahan S; Dhaliwal HS; Bhyan P; Bhattad PB; Aslam F; Ranka S; Dalia T; Chhabra L; Sanghavi D; Sonani B; Davis JM
    Ann Med; 2021 Dec; 53(1):117-134. PubMed ID: 33095083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Globular deposits of immunoglobulins and complement in the papillary dermis. Clinical significance.
    Gogate P; Valenzuela R; Deodhar SD; Bergfeld WF; Yeip M
    Am J Clin Pathol; 1980 Apr; 73(4):512-7. PubMed ID: 7369175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of COVID 19-Repurposing drugs commonly used in dermatology.
    Stojkovic-Filipovic J; Bosic M
    Dermatol Ther; 2020 Sep; 33(5):e13829. PubMed ID: 32542964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
    Hinterseher J; Hertl M; Didona D
    J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lichen Planus Eruption Following Oxford-AstraZeneca COVID-19 Vaccine Administration: A Case Report and Review of Literature.
    Alrawashdeh HM; Al-Habahbeh O; Naser AY; Abu Serhan H; Hamdan O; Sweiss K; Aldalameh Y
    Cureus; 2022 Feb; 14(2):e22669. PubMed ID: 35386174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
    Wallace DJ
    Lupus; 1996 Jun; 5 Suppl 1():S59-64. PubMed ID: 8803913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.